Literature DB >> 25100377

Pituitary apoplexy in nonfunctioning pituitary macroadenomas: a case-control study.

Guadalupe Vargas1, Baldomero Gonzalez2, Gerardo Guinto3, Victoria Mendoza1, Blas López-Félix4, Erick Zepeda4, Moisés Mercado2.   

Abstract

OBJECTIVE: Pituitary apoplexy (PA) is an endocrinologic emergency characterized by headache, visual abnormalities, and hemodynamic instability in the context of hemorragic infarction of a pituitary adenoma. Our goal was to estimate the incidence, precipitating factors, clinical characteristics, and outcome of PA in a cohort of patients with nonfunctioning pituitary macroadenomas (NFPMAs).
METHODS: A retrospective, case-control study of 46 patients with PA and 47 controls matched for age, gender, and tumor invasiveness. Clinical, hormonal, and tumoral charactersitics, as well as the presence of potential precipitating factors and long-term outcome were evaluated using both bivariate and multivariate analysis.
RESULTS: The prevalence of PA was 8%. Cases and controls were similar in regards to the prevalence of diabetes, hypertension, use of antiplatelet agents, and the presence of headaches and visual field defects. Oculomotor paralysis was present in 18% of cases and in none of the controls (P = .001). Prior use of dopamine agonists was significantly more frequent among cases than in controls on both bivariate and multivariate analysis. Pituitary hormone deficiencies were more common among cases than in controls on bivariate but not on multivariate analysis. Early and late surgical treatment was carried out in 11 and 25 patients, respectively; 11 patients were managed conservatively. Visual and endocrine outcomes were similar among the 3 groups.
CONCLUSION: PA represents a life-threatening medical emergency. Prior use of dopamine agonists and the presence of oculomotor abnormalities clearly distinguished patients with NFPMA who developed PA from those who did not.

Entities:  

Mesh:

Year:  2014        PMID: 25100377     DOI: 10.4158/EP14120.OR

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  9 in total

Review 1.  Apoplexy in nonfunctioning pituitary adenomas.

Authors:  Luiz Eduardo Wildemberg; Andrea Glezer; Marcello D Bronstein; Mônica R Gadelha
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

2.  The Effect of Timing of Surgery in Pituitary Apoplexy on Continuously Valued Visual Acuity.

Authors:  Patrick D Kelly; Shanik J Fernando; Jordan A Malenke; Rakesh K Chandra; Justin H Turner; Lola B Chambless
Journal:  J Neurol Surg B Skull Base       Date:  2020-01-24

3.  Pituitary injury and persistent hypofunction resulting from a peripartum non-hemorrhagic, vaso-occlusive event.

Authors:  Anita Kuriya; David V Morris; Michael H Dahan
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-06-01

4.  Brain and Optic Chiasm Herniation into Sella after Pituitary Tumor Apoplexy.

Authors:  Maria M Pineyro; Patricia Furtenbach; Ramiro Lima; Saul Wajskopf; Nicolas Sgarbi; Raul Pisabarro
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-07       Impact factor: 5.555

5.  Pituitary Apoplexy Presenting as Ophthalmoplegia and Altered Level of Consciousness without Headache.

Authors:  Nooshin Salehi; Anthony Firek; Iqbal Munir
Journal:  Case Rep Endocrinol       Date:  2018-05-09

6.  Apoplexy of Crooke cell tumour leading to the diagnosis of severe Cushing disease; a case report.

Authors:  Nipun Lakshitha de Silva; Noel Somasundaram; Roshana Constantine; Himashi Kularatna
Journal:  BMC Endocr Disord       Date:  2021-05-01       Impact factor: 3.263

7.  Ischemic Infarction of Pituitary Apoplexy: A Retrospective Study of 46 Cases From a Single Tertiary Center.

Authors:  Qiang Zhu; Yuchao Liang; Ziwen Fan; Yukun Liu; Chunyao Zhou; Hong Zhang; Tianshi Li; Yanpeng Zhou; Jianing Yang; Yinyan Wang; Lei Wang
Journal:  Front Neurosci       Date:  2022-01-24       Impact factor: 4.677

8.  Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas.

Authors:  Kinga Németh; Nikolette Szücs; Sándor Czirják; Lilla Reiniger; Borbála Szabó; Gábor Barna; Katalin Karászi; Péter Igaz; Vladimir Zivkovic; Márta Korbonits; Attila Patócs; Henriett Butz
Journal:  Oncotarget       Date:  2018-06-26

9.  A novel "total pituitary hormone index" as an indicator of postoperative pituitary function in patients undergoing resection of pituitary adenomas.

Authors:  Shousen Wang; Biao Li; Chenyu Ding; Deyong Xiao; Liangfeng Wei
Journal:  Oncotarget       Date:  2017-03-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.